| 摘要 |
The present invention provides a pharmaceutical composition for use as a Th2 differentiation inhibitor comprising a compound represented by Formula (I): <CHEM> wherein each of ring A, ring B and ring C is an aromatic carbocyclic ring, a heterocyclic ring and the like, X is a single bond, -O-, -CH2-, -NH-, -SO- and the like, Y is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl and the like, each of V<1> and V<2> is a single bond, -O-, -NH-, -OCH2- and the like, a prodrug, pharmaceutically acceptable salt or solvate thereof. |
